Priority Date: 30.05.16 (EP 20160171885)

METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS

  • Application ID: EP17728484
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class G01 (MEASURING; TESTING). MorphoSys AG is specialized in G01. MorphoSys AG is specialised in G01 (MEASURING; TESTING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 30.05.2016 - Priority Date (EP 20160171885)
  • 07.12.2017 - Publication A1 (WO2017207574)
  • 10.04.2019 - Publication A1 (EP3465214)

IPC Classification